{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:49:36Z","timestamp":1777697376912,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.toxlet.2024.09.005","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T22:28:47Z","timestamp":1726180127000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of a scintillation proximity assay for [3H]epibatidine binding sites of Tetronarce californica muscle-type nicotinic acetylcholine receptor"],"prefix":"10.1016","volume":"401","author":[{"given":"Fabian","family":"Springer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Freisleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Muschik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Worek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"Meinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin Veronika","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxlet.2024.09.005_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.toxlet.2024.09.005_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-4547(19960415)44:2<97::AID-JNR1>3.0.CO;2-B","article-title":"Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor","volume":"44","author":"Arias","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.toxlet.2024.09.005_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-381264-3.00005-9","article-title":"Positive and negative modulation of nicotinic receptors","author":"Arias","year":"2010","journal-title":"Adv. Protein Chem. Struct. Biol. 80"},{"issue":"2","key":"10.1016\/j.toxlet.2024.09.005_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1085\/jgp.112.2.181","article-title":"Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism","volume":"112","author":"Auerbach","year":"1998","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.toxlet.2024.09.005_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.ctm.2017.05.002","article-title":"The role of cholesterol in the activation of nicotinic acetylcholine receptors","author":"Baenziger","year":"2017","journal-title":"Curr. Top. Membr. 80"},{"issue":"1-3","key":"10.1016\/j.toxlet.2024.09.005_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresrev.2004.06.008","article-title":"Structural basis for lipid modulation of nicotinic acetylcholine receptor function","volume":"47","author":"Barrantes","year":"2004","journal-title":"Brain Res. Rev."},{"issue":"18","key":"10.1016\/j.toxlet.2024.09.005_bib7","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.analchem.7b02329","article-title":"Effect of DMSO on protein structure and interactions assessed by collision-induced dissociation and unfolding","volume":"89","author":"Chan","year":"2017","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.toxlet.2024.09.005_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bcp.2015.07.028","article-title":"Allosteric modulation of nicotinic acetylcholine receptors","volume":"97","author":"Chatzidaki","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"23","key":"10.1016\/j.toxlet.2024.09.005_bib9","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"26","key":"10.1016\/j.toxlet.2024.09.005_bib10","doi-asserted-by":"crossref","first-page":"17819","DOI":"10.1074\/jbc.M900030200","article-title":"A lipid-dependent uncoupled conformation of the acetylcholine receptor","volume":"284","author":"daCosta","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.toxlet.2024.09.005_bib11","doi-asserted-by":"crossref","first-page":"33841","DOI":"10.1074\/jbc.M109.048280","article-title":"Anionic lipids allosterically modulate multiple nicotinic acetylcholine receptor conformational equilibria","volume":"284","author":"daCosta","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.toxlet.2024.09.005_bib12","doi-asserted-by":"crossref","first-page":"14967","DOI":"10.1074\/jbc.M310037200","article-title":"Phosphatidic acid and phosphatidylserine have distinct structural and functional interactions with the nicotinic acetylcholine receptor","volume":"279","author":"daCosta","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2024.09.005_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.irn.2015.07.001","article-title":"Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine","author":"Dani","year":"2015","journal-title":"Int. Rev. Neurobiol. 124"},{"issue":"3","key":"10.1016\/j.toxlet.2024.09.005_bib14","first-page":"179","article-title":"Alcohol's actions on neuronal nicotinic acetylcholine receptors","volume":"29","author":"Davis","year":"2006","journal-title":"Alcohol. Res. Health.: J. Natl. Inst. Alcohol. Abus. Alcohol."},{"issue":"9612","key":"10.1016\/j.toxlet.2024.09.005_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","article-title":"Management of acute organophosphorus pesticide poisoning","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet"},{"issue":"9495","key":"10.1016\/j.toxlet.2024.09.005_bib16","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(05)67598-8","article-title":"Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study","volume":"366","author":"Eddleston","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2024.09.005_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2016.00114","article-title":"Potentiation of gamma aminobutyric acid receptors (GABAAR) by ethanol: how are inhibitory receptors affected?","volume":"10","author":"F\u00f6rstera","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.toxlet.2024.09.005_bib18","first-page":"567","article-title":"Pharmacology of organophosphorus cholinesterase inhibitors","volume":"11","author":"HOLMSTEDT","year":"1959","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.toxlet.2024.09.005_bib19","first-page":"280","article-title":"Characterization of (+\/-)(-)3Hepibatidine binding to nicotinic cholinergic receptors in rat and human brain","volume":"48","author":"Houghtling","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.toxlet.2024.09.005_bib20","first-page":"1561","article-title":"Alcohol-binding sites in distinct brain proteins: the quest for atomic level resolution","volume":"35","author":"Howard","year":"2011","journal-title":"Alcohol., Clin. Exp. Res."},{"key":"10.1016\/j.toxlet.2024.09.005_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.toxlet.2022.11.018","article-title":"A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment","volume":"373","author":"Kaiser","year":"2023","journal-title":"Toxicol. Lett."},{"issue":"15","key":"10.1016\/j.toxlet.2024.09.005_bib22","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/j.1742-4658.2007.05935.x","article-title":"Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity","volume":"274","author":"Kalamida","year":"2007","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.toxlet.2024.09.005_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Emerging structure of the nicotinic acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.toxlet.2024.09.005_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1271\/bbb.63.1321","article-title":"Effects of high pressure on lipids and biomembranes for understanding high-pressure-induced biological phenomena","volume":"63","author":"Kato","year":"1999","journal-title":"Biosci., Biotechnol., Biochem."},{"issue":"3","key":"10.1016\/j.toxlet.2024.09.005_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2007.12.044","article-title":"Epibatidine binds to four sites on the Torpedo nicotinic acetylcholine receptor","volume":"366","author":"Kawai","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.toxlet.2024.09.005_bib26","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1016\/S0021-9258(17)39005-1","article-title":"Primary structures of the catalytic subunits from two molecular forms of acetylcholinesterase. A comparison of NH2-terminal and active center sequences","volume":"260","author":"MacPhee-Quigley","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.toxlet.2024.09.005_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0163-7258(93)90066-M","article-title":"Organophosphate poisoning","volume":"58","author":"Marrs","year":"1993","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.toxlet.2024.09.005_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00139709-200625040-00009","article-title":"The role of oximes in the treatment of nerve agent poisoning in civilian casualties","volume":"25","author":"Marrs","year":"2006","journal-title":"Toxicol. Rev."},{"issue":"16","key":"10.1016\/j.toxlet.2024.09.005_bib29","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.160128797","article-title":"Specific binding sites for alcohols and anesthetics on ligand-gated ion channels","volume":"97","author":"Mascia","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6649","key":"10.1016\/j.toxlet.2024.09.005_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/38738","article-title":"Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.","volume":"389","author":"Mihic","year":"1997","journal-title":"Nature"},{"issue":"4676","key":"10.1016\/j.toxlet.2024.09.005_bib31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bmj.2.4676.444","article-title":"Parathion poisoning","volume":"2","author":"MILLES","year":"1950","journal-title":"Br. Med. J."},{"key":"10.1016\/j.toxlet.2024.09.005_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1113\/jphysiol.1987.sp016489","article-title":"Surplus acetylcholine and acetylcholine release in the rat diaphragm","volume":"385","author":"Molenaar","year":"1987","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxlet.2024.09.005_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.toxlet.2017.10.009","article-title":"In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers","volume":"293","author":"Niessen","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.toxlet.2024.09.005_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cbi.2013.10.012","article-title":"Affinities of bispyridinium non-oxime compounds to (3)Hepibatidine binding sites of Torpedo californica nicotinic acetylcholine receptors depend on linker length","volume":"206","author":"Niessen","year":"2013","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.toxlet.2024.09.005_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2011.06.009","article-title":"Interaction of bispyridinium compounds with the orthosteric binding site of human \u03b17 and Torpedo californica nicotinic acetylcholine receptors (nAChRs)","volume":"206","author":"Niessen","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.toxlet.2024.09.005_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.01.029","article-title":"Merging old and new perspectives on nicotinic acetylcholine receptors","volume":"89","author":"Papke","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.toxlet.2024.09.005_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0003-2697(86)90091-6","article-title":"Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions","volume":"153","author":"Redinbaugh","year":"1986","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.toxlet.2024.09.005_bib38","first-page":"656","article-title":"Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure","volume":"289","author":"Reitstetter","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2024.09.005_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.129425","article-title":"Recent developments of organic solvent resistant materials for membrane separations","volume":"271","author":"Ren","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.toxlet.2024.09.005_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.toxlet.2017.11.013","article-title":"Development of MS Binding Assays targeting the binding site of MB327 at the nicotinic acetylcholine receptor","volume":"293","author":"Sichler","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"7083","key":"10.1016\/j.toxlet.2024.09.005_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04708","article-title":"Recent advances in Cys-loop receptor structure and function","volume":"440","author":"Sine","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.toxlet.2024.09.005_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.toxlet.2024.09.005_bib43","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1113\/jphysiol.2013.267781","article-title":"Agonists binding nicotinic receptors elicit specific channel-opening patterns at \u03b1\u03b3 and \u03b1\u03b4 sites","volume":"592","author":"Stock","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.toxlet.2024.09.005_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0378-4274(95)03575-3","article-title":"Structural bases for the specificity of cholinesterase catalysis and inhibition","volume":"82-83","author":"Taylor","year":"1995","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.toxlet.2024.09.005_bib45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jmb.2012.07.010","article-title":"Gating movement of acetylcholine receptor caught by plunge-freezing","volume":"422","author":"Unwin","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.toxlet.2024.09.005_bib46","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"Pt B)","key":"10.1016\/j.toxlet.2024.09.005_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cbi.2016.04.032","article-title":"Oximes in organophosphate poisoning: 60 years of hope and despair","volume":"259","author":"Worek","year":"2016","journal-title":"Chem. -Biol. Interact."},{"issue":"7","key":"10.1016\/j.toxlet.2024.09.005_bib48","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-020-02797-0","article-title":"Organophosphorus compounds and oximes: a critical review","volume":"94","author":"Worek","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.toxlet.2024.09.005_bib49","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bcp.2011.07.067","article-title":"Naturally-expressed nicotinic acetylcholine receptor subtypes","volume":"82","author":"Wu","year":"2011","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424020307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424020307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T01:06:52Z","timestamp":1730336812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427424020307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"alternative-id":["S0378427424020307"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.09.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a scintillation proximity assay for [3H]epibatidine binding sites of Tetronarce californica muscle-type nicotinic acetylcholine receptor","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}